A paradigm for Africa-centric vaccine development in Equatorial Guinea.
Trends Parasitol
; 40(5): 362-366, 2024 May.
Article
in En
| MEDLINE
| ID: mdl-38582683
ABSTRACT
The Equatorial Guinea Malaria Vaccine Initiative (EGMVI) highlights how long-term African government and international energy industry investment, plus novel partnerships, can enable clinical development of vaccines in Africa, for Africa. We review achievements and challenges of this pioneering, award-winning, public-private partnership which offers a model for future Africa-centric clinical research and development (R&D).
Key words
Full text:
1
Database:
MEDLINE
Main subject:
Malaria Vaccines
/
Vaccine Development
Limits:
Humans
Country/Region as subject:
Africa
Language:
En
Journal:
Trends Parasitol
Journal subject:
PARASITOLOGIA
Year:
2024
Type:
Article